You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 Trial in Worldwide

Active, not recruiting
  • Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19
  • Ad26.COV2.S
  • Placebo
  • Vestavia Hills, Alabama
  • +125 more
Jan 17, 2023

Healthy Trial in Groningen (Ad26.COV2.S)

Completed
  • Healthy
  • Ad26.COV2.S
  • Groningen, Netherlands
    PRA Health Sciences
Dec 21, 2021

SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

Recruiting
  • SARS-CoV-2 Infection
  • B/HPIV3/S-6P
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Aug 30, 2023

Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)

Not yet recruiting
  • Sudan Ebola Virus Vaccines
  • CAd3
  • +3 more
  • (no location specified)
Jun 8, 2023

Ebola Virus Disease Trial in Kampala (Ebola+D intervention)

Recruiting
  • Ebola Virus Disease
  • Ebola+D intervention
  • Kampala, Uganda
    Mubende Regional Referal Hospital
Oct 19, 2023

Kidney Transplant Recipient Trial in Phoenix, Jacksonville, Rochester (Janssen Ad26.CoV2.S Vaccine, Reduction in

Recruiting
  • Kidney Transplant Recipient
  • Janssen Ad26.CoV2.S Vaccine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jul 14, 2022

Advanced/Metastatic Solid Tumours Trial in Canada (MG1MA3, AdMA3)

Active, not recruiting
  • Advanced/Metastatic Solid Tumours
  • MG1MA3
  • AdMA3
  • Vancouver, British Columbia, Canada
  • +3 more
Jan 30, 2023

Ebola Virus Disease Trial in N'Zerekore (ansuvimab, Ervebo)

Not yet recruiting
  • Ebola Virus Disease
  • N'Zerekore, Guinea
    Centre de Traitement Ebola de N'Zerekore
Oct 14, 2021

Healthy Trial in Fukuoka (RSV Vaccine, Placebo)

Completed
  • Healthy
  • RSV Vaccine
  • Placebo
  • Fukuoka, Japan
    Souseikai Hakata Clinic
Feb 16, 2021

Ebola Trial in Oxford (ChAdOx1 biEBOV)

Recruiting
  • Ebola
  • ChAdOx1 biEBOV
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022

SARS-CoV-2 Infection Trial in Bangkok (Full dose of Ad26.COV2. 5x10^10vp, Half dose of Ad26.COV2. 2.5x10^10vp)

Recruiting
  • SARS-CoV-2 Infection
  • Full dose of Ad26.COV2. 5x10^10vp
  • Half dose of Ad26.COV2. 2.5x10^10vp
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Sep 11, 2022

Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)

Not yet recruiting
  • Ebola Virus Disease
  • Zabdeno® booster
  • Ervebo® booster
  • Goma, Congo, The Democratic Republic of the
  • +1 more
Nov 6, 2023

Pompe Disease Infantile-Onset Trial in China (GC301)

Not yet recruiting
  • Pompe Disease Infantile-Onset
  • GC301
  • Beijing, China
  • +4 more
Apr 2, 2023

COVID-19, Vaccine Reaction, SARS CoV 2 Infection Trial in Bamako (Ad26.COV2.S, NVX-CoV2373)

Not yet recruiting
  • COVID-19
  • +3 more
  • Ad26.COV2.S
  • NVX-CoV2373
  • Bamako, Mali
    CVD-MALI
Jun 7, 2022

Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

Not yet recruiting
  • Adenovirus
  • +2 more
  • Specific T- Lymphocytes
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 8, 2023

Host Genetic Factors Underlying Ebola Virus Disease Risk,

Completed
  • Ebola Virus Disease
    • Kalkata, Liberia
    • +3 more
    Aug 18, 2022

    Covid-19 Prevention Trial in Belgium, United States (Ad26.COV2.S, Placebo)

    Active, not recruiting
    • Covid-19 Prevention
    • Ad26.COV2.S
    • Placebo
    • San Diego, California
    • +11 more
    Mar 15, 2022

    Adenovirus Infection, BK Virus Infection, Cytomegalovirus Infections Trial in Worldwide (Posoleucel (ALVR105), Placebo)

    Recruiting
    • Adenovirus Infection
    • +5 more
    • Posoleucel (ALVR105)
    • Placebo
    • Birmingham, Alabama
    • +60 more
    Mar 30, 2022

    Comparative Evaluation of Covid-19 Vaccines Response

    Recruiting
    • COVID-19 Vaccines
    • Covid-19 Inactive Vaccine, recombinant human adenovirus serotype number 26, mRNA VAccine
    • Karaman, Turkey
    • +3 more
    Jul 11, 2021

    Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

    Enrolling by invitation
    • Malignant Melanomas
    • Recombinant Human Adenovirus Type 5 Injection
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
    Jul 7, 2023

    Hemophilia B Trial in Worldwide (AAV5-hFIXco-Padua)

    Active, not recruiting
    Has Results
    • Hemophilia B
    • AAV5-hFIXco-Padua
    • Factor IX (FIX)
    • Phoenix, Arizona
    • +32 more
    Sep 26, 2022

    SARS-CoV-2 Infection Trial in Mexico (AVX-COVID/12, ChAdOx-1-S[recombinant])

    Recruiting
    • SARS-CoV-2 Infection
    • AVX-COVID/12
    • ChAdOx-1-S[recombinant]
    • Mexico City, Cdmx, Mexico
    • +13 more
    Feb 3, 2023

    Human Papillomavirus Infections Trial in Belgium, United States (Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18)

    Terminated
    Has Results
    • Human Papillomavirus Infections
    • Ad26.HPV16
    • +3 more
    • Doral, Florida
    • +11 more
    Nov 23, 2021

    Covid19 Trial in Halifax, Ottawa, Toronto (VBI-2902a, Placebo, VBI-2905a)

    Active, not recruiting
    • Covid19
    • VBI-2902a
    • +2 more
    • Halifax, Nova Scotia, Canada
    • +3 more
    Jul 18, 2022

    Viral Infections After HSCT Trial in Washington (VSTs)

    Active, not recruiting
    • Viral Infections After HSCT
    • VSTs
    • Washington, District of Columbia
      Childrens National Medical Center
    Aug 30, 2022